Development and clinical application of a liquid chromatography-tandem mass spectrometry-based assay to quantify eight tyrosine kinase inhibitors in human plasma

INTRODUCTION: Tyrosine kinase inhibitors (TKIs) are widely used in tumor treatment. The detection of these medicines by liquid chromatography-tandem mass spectrometry (LC-MS/MS) can avoid the interference of structurally similar compounds. OBJECTIVES: This study aimed to develop and validate a new L...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fangjun, Chen, Wenda, Wang, Zhenxin, Peng, Yingfei, Wang, Beili, Pan, Baishen, Guo, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205537/
https://www.ncbi.nlm.nih.gov/pubmed/37234251
http://dx.doi.org/10.1016/j.jmsacl.2023.05.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10205537/
https://www.ncbi.nlm.nih.gov/pubmed/37234251
http://dx.doi.org/10.1016/j.jmsacl.2023.05.001

Ejemplares similares